Kite’s CAR T-Cell Therapy Success – The Scientist
The Scientist |
Kite's CAR T-Cell Therapy Success
The Scientist CAR T cell success in lymphoma Follicular lymphoma in bone marrowFLICKR, ED UTHMANSix months after receiving infusions of their own T cells—genetically engineered ex vivo to carry chimeric antigen receptors (CAR) that bind to proteins on the surface … With Eye On FDA, Kite Says CAR–T For Lymphoma Holds Up After 6 Months Kite's CAR–T cancer therapy shows strong results as company races to win FDA approval Kite Pharma CAR–T Cancer Therapy Shows Strong, Durable Effect in Lymphoma Patients |
